BDNF and myelodysplastic syndrome: Evidence that impairments in neural plasticity are implicated in MDs [103] and that PA modulates common neuroplasticity substrates (neurotransmitters, synaptic number and function, neurogenesis, BDNF, inflammation, stress reactivity, antioxidant defense, circadian rhythm, epigenetic modifications, and alteration of telomere length) in MDD and BP has led to numerous attempts to harness neuroplasticity to promote healing and recovery [134], particularly as it applies to psychiatric disease [135, 136].